Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 1
2007 1
2009 3
2010 2
2012 1
2013 2
2014 3
2015 3
2016 8
2017 8
2018 8
2019 16
2020 14
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
De Mattia E, Cecchin E, Guardascione M, Foltran L, Di Raimo T, Angelini F, D'Andrea M, Toffoli G. De Mattia E, et al. Among authors: cecchin e. World J Gastroenterol. 2019 Aug 7;25(29):3870-3896. doi: 10.3748/wjg.v25.i29.3870. World J Gastroenterol. 2019. PMID: 31413525 Free PMC article. Review.
Circulating-Free DNA Analysis in Hepatocellular Carcinoma: A Promising Strategy to Improve Patients' Management and Therapy Outcomes.
Mezzalira S, De Mattia E, Guardascione M, Dalle Fratte C, Cecchin E, Toffoli G. Mezzalira S, et al. Among authors: cecchin e. Int J Mol Sci. 2019 Nov 5;20(21):5498. doi: 10.3390/ijms20215498. Int J Mol Sci. 2019. PMID: 31694149 Free PMC article. Review.
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma.
Dal Bo M, De Mattia E, Baboci L, Mezzalira S, Cecchin E, Assaraf YG, Toffoli G. Dal Bo M, et al. Among authors: cecchin e. Drug Resist Updat. 2020 Jul;51:100702. doi: 10.1016/j.drup.2020.100702. Epub 2020 Apr 19. Drug Resist Updat. 2020. PMID: 32371296 Free article. Review.
Genetic Markers of the Host to Predict the Efficacy of Colorectal Cancer Targeted Therapy.
De Mattia E, Bignucolo A, Toffoli G, Cecchin E. De Mattia E, et al. Among authors: cecchin e. Curr Med Chem. 2020;27(25):4249-4273. doi: 10.2174/0929867326666190712151417. Curr Med Chem. 2020. PMID: 31298142 Review.
Improving decision making on DPYD and UGT1A1*28 patients' profiling with an innovative reimbursement strategy.
Roncato R, Cecchin E, Toffoli G. Roncato R, et al. Among authors: cecchin e. Pharmacogenomics. 2018 Mar;19(4):301-304. doi: 10.2217/pgs-2017-0303. Epub 2018 Feb 14. Pharmacogenomics. 2018. PMID: 29441806 No abstract available.
Pharmacogenomics and Personalized Medicine.
Cecchin E, Stocco G. Cecchin E, et al. Genes (Basel). 2020 Jun 22;11(6):679. doi: 10.3390/genes11060679. Genes (Basel). 2020. PMID: 32580376 Free PMC article.
Host genetic profiling to increase drug safety in colorectal cancer from discovery to implementation.
Cecchin E, De Mattia E, Ecca F, Toffoli G. Cecchin E, et al. Drug Resist Updat. 2018 Jul;39:18-40. doi: 10.1016/j.drup.2018.07.001. Epub 2018 Jul 10. Drug Resist Updat. 2018. PMID: 30075835 Review.
Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.
Bignucolo A, De Mattia E, Cecchin E, Roncato R, Toffoli G. Bignucolo A, et al. Among authors: cecchin e. Int J Mol Sci. 2017 Jul 14;18(7):1522. doi: 10.3390/ijms18071522. Int J Mol Sci. 2017. PMID: 28708103 Free PMC article. Review.
Nuclear receptors and drug metabolism for the personalization of cancer therapy.
Cecchin E, De Mattia E, Toffoli G. Cecchin E, et al. Expert Opin Drug Metab Toxicol. 2016;12(3):291-306. doi: 10.1517/17425255.2016.1141196. Epub 2016 Feb 1. Expert Opin Drug Metab Toxicol. 2016. PMID: 26789519 Review.
Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts.
Just KS, Turner RM, Dolžan V, Cecchin E, Swen JJ, Gurwitz D, Stingl JC. Just KS, et al. Among authors: cecchin e. Clin Pharmacol Ther. 2019 Aug;106(2):313-316. doi: 10.1002/cpt.1471. Epub 2019 Jun 25. Clin Pharmacol Ther. 2019. PMID: 31237679 Free PMC article. No abstract available.
69 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page